The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study
For NPC patients with RCLN, adding a boost dosage following radical IMRT results in desirable tumor control and a positive clinical outcome. Individuals with detectable EBV DNA and N2-3 category may benefit from the boost radiation.
Authors
- Jianming Ding (ORCID: https://orcid.org/0000-0001-6059-0901)
- Zhaodong Fei (ORCID: https://orcid.org/0000-0001-8148-1763)
- Lei Wang (ORCID: https://orcid.org/0000-0002-7163-3644)
- Mengting Xu (ORCID: https://orcid.org/0000-0003-1506-2469)
- Yiying Xu
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1186/s12885-025-13665-4
- Citations
- 2
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.70